Interchange Capital Partners LLC Makes New Investment in Medicus Pharma Ltd. (NASDAQ:MDCX)

Interchange Capital Partners LLC bought a new position in shares of Medicus Pharma Ltd. (NASDAQ:MDCX) in the fourth quarter, HoldingsChannel.com reports. The firm bought 1,457,165 shares of the company’s stock, valued at approximately $3,628,000. Medicus Pharma makes up 1.3% of Interchange Capital Partners LLC’s portfolio, making the stock its 15th largest position. Interchange Capital Partners LLC owned 0.13% of Medicus Pharma as of its most recent SEC filing.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Brookline Capital Management upgraded Medicus Pharma to a “strong-buy” rating in a report on Monday, December 23rd. Maxim Group began coverage on Medicus Pharma in a report on Tuesday, December 17th. They set a “buy” rating and a $10.00 target price for the company.

Medicus Pharma Stock Performance

Shares of MDCX stock opened at $3.32 on Monday. The business’s fifty day simple moving average is $3.16. Medicus Pharma Ltd. has a 12-month low of $1.80 and a 12-month high of $6.00.

Medicus Pharma Profile

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.